# Q3C(R8) Impurities: Guidance for Residual Solvents   Guidance for Industry:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q3cr8-impurities-guidance-for-residual-solvents-guidance-for-industry-guidance-for-industry/5d102000-693a-43cc-8f78-dc661ff31752

> FDA guidance document: Q3C(R8) Impurities: Guidance for Residual Solvents   Guidance for Industry:  Guidance for Industry. Issue date: December 10, 2021. Get complete insights and analysis.

---

## Details

- Title: Q3C(R8) Impurities: Guidance for Residual Solvents   Guidance for Industry:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2021-12-10
- Last Changed: 2021-12-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-1301">FDA-2020-D-1301</a>

## Related Documents

- [M9 Biopharmaceutics Classification System-Based Biowaivers](https://www.globalkeysolutions.net/guidances/guidance-document/m9-biopharmaceutics-classification-system-based-biowaivers/bf9d33a6-a7bf-4b4e-bf7a-2a88d1e6d1cf)
- [E11A Pediatric Extrapolation](https://www.globalkeysolutions.net/guidances/guidance-document/e11a-pediatric-extrapolation/01ffe475-9ecf-45c9-ad29-f4b2a89bcb52)
- [Homeopathic Drug Products Guidance for FDA Staff and Industry](https://www.globalkeysolutions.net/guidances/guidance-document/homeopathic-drug-products-guidance-for-fda-staff-and-industry/f8c7cdc9-599a-4ab0-9f93-eeb2b899427c)